J Nutr Sci Vitaminol, 60, [261] [262] [263] [264] [265] [266] [267] [268] 2014 l-Tryptophan (l-Trp) is a toxic amino acid (1) . Its median lethal dose (LD50) is 1.6 g/kg body weight if injected via the intraperitoneal route into rats (2) . The toxic mechanisms of l-Trp are not well known. We reported that in growing rats, gain in body weight was suppressed by feeding a diet containing 5.0% l-Trp, but not by feeding a diet containing 2.0% l-Trp (3) . We also reported that the urinary excretory ratio of anthranilic acid (AnA)/kynurenic acid (KA) could be a useful index to monitor excessive intake of l-Trp in rats (3) . In addition, we showed that supplementation with #5.0 g/d of l-Trp produces no adverse effects, and that the response of 3-hydroxykynurenine (3-HK) is the most characteristic of l-Trp metabolites in healthy women (4) . This finding suggests that the urinary excretion of 3-HK is a good surrogate biomarker for excess ingestion of l-Trp (4) .
The efficiency of utilization of d-Trp for growth differs considerably among species. Mice (5) , humans (6) , rabbits (7) and chickens (8) utilize d-Trp poorly. Dogs utilize d-Trp more efficiently than humans (9, 10) , but less efficiently than rats, who utilize it almost completely (10) . For pigs, d-Trp is 60-70% as effective as l-Trp (11, 12) . As described above, the effects of the replacement of d-Trp by l-Trp have been clarified (5) (6) (7) (8) (9) (10) (11) (12) , but information about the toxicity of d-Trp is scant.
In the present study, we first investigated how much d-Trp needs to be added to a conventional diet to reduce the body-weight gain and food intake of growing rats. to these conditions, they were initially fed ad libitum for 7 d with an NiA-free, 20% casein diet (control diet; Table 1 ). One of the groups was fed with a 20% casein diet as a control, and the others were fed a 20% casein diet that had 0.1, 0.2, 0.3, 0.4, or 0.5% d-Trp added to it ( Table 1 ). All animals had free access to food and water. The animal room was maintained at a temperature of about 20˚C, 60% humidity and a 12-h light-dark cycle (lights on at 6 am). Body weight and food intake were measured daily at around 9 am, and food and water renewed daily. The experimental period was 21 d. Urine (9 am to 9 am; 24-h urine) was collected on the last day of the experiment. One portion of the urine was stored at 220˚C until needed, and the remainder was added to 0.1 mol/L HCl (final concentration), and then stored at 220˚C until required.
Analyses of Trp and its metabolites. The amount of Trp (sum of d-Trp and l-Trp) (16) and its metabolites, such as Kyn (d-Kyn1l-Kyn) (17), AnA (18), KA (19), 3-HK (d-3-HK1l-3-HK) (20) , XA (21), 3-HA (21), QA (22) , MNA (23), Nam (14), 2-Py (14), 4-Py (14), 5-HIAA (24), and 2-OAA (25), in urine was determined by high-performance liquid chromatography (HPLC).
Statistical analyses. Values are the mean6SE. Significance was determined by one-way ANOVA, followed by Tukey's multiple-comparison test. p,0.05 was considered to be significant. All statistical analyses were undertaken using Prism v5.0 (GraphPad Software, San Diego, CA).
RESULTS

Effect of d-Trp intake on gain in body weight and food intake
On the final day of the experiment (day 21), the gain in body weight was not significantly different among the groups (Fig. 1A ). Periodic adverse effects of d-Trp on changes in body weight were observed on days 7, 14, and 21 (Figs. 1B-D). Adverse effects were observed in the group fed the 0.3% d-Trp diet, but not in the group Daily food intakes among the groups are shown in Fig. 2A . Periodic adverse effects of d-Trp on total food intake were observed on days 1-7, 1-14, and 1-21 (Figs. 2B-D). Adverse effects were observed in the group fed the 0.3% d-Trp diet, but not in the group fed the 0.2% d-Trp diet for 7, 14, and 21 d.
These findings suggested that the adverse effects of d-Trp were observed when the rats were the fed 0.3% d-Trp diet but not the 0.2% d-Trp diet. That is, a break point in the gain in body weight was detected between the groups of 0.2% and 0.3% d-Trp. Hence, a diet containing 0.2% d-Trp was considered to cause none of the adverse effects associated with d-Trp (0.15 g/ kg body weight/d). The average daily intake of d-Trp in the group fed 0.3% d-Trp was 54 mg/d (average total food intake, 374.5 g/21 d; average total d-Trp intake, 1,124 mg/21 d; average daily intake of d-Trp, Table 2 . Effects of d-Trp addition on urinary excretion of Trp and its catabolites in rats.
Food intake on day 21 Dietary D-Trp content (%) Total food intake from 0 to 21 d (g/21 d) 53.5 mg/d). The average body weight during the experiment in the group fed the 0.3% d-Trp diet was 257.8 g, so the daily intake of d-Trp per kg of body weight was 0.21 g (53.5 mg/d of d-Trp/0.2578 kg of body weight5207.5 mg/kg of body weight per day). This confirmed that the feeding of the 0.2% d-Trp diet did not elicit adverse effects. The average daily intake of d-Trp in the group fed 0.2% d-Trp was 40.5 mg/rat (average total food intake, 425.6 g/21 d; average total intake of d-Trp, 851 mg/21 d; average daily intake of d-Trp, 40.5 mg/d). The average body weight during the experiment in the group fed the 0.2% d-Trp diet was 270.9 g, so the d-Trp intake per kg of body weight was 0.15 g (40.5/0.27095149.5 mg). Table 2 shows the urinary excretion of Trp (sum of d-Trp and l-Trp) and its metabolites. The percentage urinary excretion of Trp was calculated using the formula: Percentage urinary excretion of Trp5[(urine Trp, mol/d)4(d-Trp intake, mol/d)3100]. The percentage urinary excretion of Trp increased significantly up to the addition of 0.4% d-Trp (Fig. 3) . The percentage urinary excretion of Trp was 1.5% of d-Trp ingested even in the group fed the 0.5% d-Trp diet. The Trp metabo- 
Effect of d-Trp on urinary excretion of Trp and its metabolites
Dietary D-Trp content (%) Urine 3-HK/Kyn
A lites AnA, KA, XA, 3-HA, and QA, as well as the sum of Nam, MNA, 2-Py, and 4-Py increased after the diet was changed from the 0.1% d-Trp diet to the 0.2% d-Trp diet. However, feeding the diet containing d-Trp from 0.3% to 0.5% did not increase with the d-Trp intake. Only urinary levels of Kyn and 3-HK increased according to increasing intake of d-Trp. Therefore, we focused on the metabolism Kyn→3-HK→3-HA as a surrogate indicator for preventing d-Trp toxicity. Figure 4 shows the relationship between dietary intake of d-Trp and urinary excretion of Kyn, 3-HK or 3-HA. Urinary levels of Kyn did not increase up to 0.2% d-Trp, but increased linearly from 0.3% d-Trp (Fig. 4A ). Urinary levels of 3-HK increased linearly with d-Trp intake (Fig. 4B ). Urinary levels of 3-HA did not increase with d-Trp intake, the first cutoff point of which was observed in the group fed the 0.3% d-Trp diet (Fig. 4C ). Figure 5 shows the relationship between dietary d-Trp content and the ratio of urinary levels of 3-HK/Kyn or 3-HK/3-HA. The ratio of urinary levels of 3-HK/Kyn did not change with d-Trp intake (Fig. 5A) . Conversely, the ratio of urinary levels of 3-HK/3-HA led to observation of a cutoff point in the group fed the 0.3% d-Trp diet (Fig. 5B) .
Urinary level of 3-HK/3-HA as a surrogate indicator for predicting the adverse effects of d-Trp
DISCUSSION
A schematic representation of the fate of d-Trp in rats fed the d-Trp diet is shown in Fig. 6 , and was derived from the data of Table 2 and reported data (26) (27) (28) (29) .
We investigated the adverse effects of d-Trp as indicators of change in body weight and food intake in growing rats. Adverse effects were observed in the group fed the 0.3% d-Trp diet, and the d-Trp intake in this group was 0.21 g/kg body weight. Conversely, feeding of the 0.2% d-Trp diet did not produce adverse effects, and d-Trp intake in this group was 0.15 g/kg body weight. Food intake on day 1 was lower even in groups fed 0.1% and 0.2% d-Trp diets compared to that of the control group, and food intake in these groups recovered up to that of the control group on day 2. Conversely, food intake in the groups fed 0.3%, 0.4%, and 0.5% d-Trp diets was lower compared to that of the control group for a long time. The duration of lower values in the groups fed 0.3%, 0.4%, and 0.5% d-Trp diets was much longer compared to that in the groups fed 0.1% and 0.2% d-Trp diets. This phenomenon appears to reflect metabolic adaptation to d-Trp. Previously, we reported that adverse effects were not observed up to 2.0% l-Trp in the diet, but that feeding of a 5.0% l-Trp diet caused obvious adverse effects (3) . A tentative no-adverse-effect level of $2 g/kg body weight was calculated using our data. d-Trp had much higher toxicity compared with l-Trp, and a tentative no-adverse-effect level was calculated to be 0.15 g/kg body weight.
In a dynamic equilibrium of protein metabolism, it is believed that .90% of l-Trp ingested is catabolized by the l-Trp-Kyn pathway (30, 31) . We measured the levels of metabolites of Trp when rats were fed d-Trp. Two metabolic pathways were considered. The first was d-Trp→d-N-formylkynurenine→d-Kyn→d-3-HK→ 3-HA. The second was d-Trp→indole-3-pyruvic acid (I3P)→l-Trp→l-N-formylkynurenine→l-Kyn→l-3-HK→3-HA. We already clarified that rats can fully convert d-Trp to l-Trp up to a 0.1% d-Trp diet (32) .
A portion of d-Trp that is ingested is catabolized directly to form d-N-formylkynurenine by Trp 2,3-dioxygenase in the liver and non-hepatic indoleamine 2,3-dioxygenase (33, 34) . d-N-Formylkynurenine is catalyzed to form d-Kyn by formylase. The formed d-Kyn is monooxygenated to form d-3-HK (catalyzed by Kyn 3-monooxygenase) and then d-3-HK is hydrolyzed to form 3-HA and d-alanine (catalyzed by kynureninase). 3-HA does not possess chiral carbons. In general, it is considered that the availability of d-Trp is much lower than that of l-Trp, which is a precursor of Nam. This is because the racemization of d-Trp to l-Trp is weak (35, 36) and the turnover number (kcat) of tryptophan 2,3-dioxygenase (TDO) is tenfold lower in d-Trp than in l-Trp in vitro (34, 37) . Conversely, the kcat of indoleamine 2,3-dioxygenase (IDO) for d-Trp and l-Trp is almost identical (38, 39) .
The toxicity of l-Trp and d-Trp could be mediated by I3P, which produces numerous aryl hydrocarbon receptor (AHR)-activating compounds (40, 41) . I3P from l-Trp is produced by aspartate aminotransferase (40) , and I3P from d-Trp is produced by d-amino acid oxidase (40) . The toxicity of d-Trp was higher than that of l-Trp; the amount of d-Trp that did not reduce bodyweight gain was 0.15 g/kg of body weight, whereas that of l-Trp was 2 g/kg of body weight (3). I3P production must be higher in d-Trp than in l-Trp. However, we did not measure I3P levels in the present study.
d-Kyn and d-3-HK are amino acids, so oxidative deamination by d-amino acid oxidase is probable. However, the deaminated products from d-Kyn and d-3-HK are unstable. Even if such products did form, the 2-oxo acids derived from d-Kyn and d-3-HK would cyclize spontaneously to form KA and XA, respectively. Other possible reactions are transamination reactions: d-Kyn12-oxo acid→KA1l-amino acid and d-3-HK12oxo acid→XA1l-amino acid (catalyzed by Kyn aminotransferases (KATs)). Three KATs have been reported in mammals: KAT-I/glutamate aminotransferase, KAT-II/ aminoadipate aminotransferase, and KAT-III/mitochondrial aspartate aminotransferase (42) . We consider that few of such transaminase reactions occur because of the low specificity of these transaminases for d-amino acids. Thus, an important issue is to recognize the over intake of d-Trp. We, then, propose the urinary ratio of 3HK/3-HA for an indicator to predict the over intake of d-Trp (3).
To survey potential indicators for preventing d-Trp toxicity, we measured the levels of 14 types of Trp metabolites. Urinary excretion of Trp itself increased abruptly at the cutoff point of feeding the 0.3% d-Trp diet. Urinary excretion of Kyn increased at the cutoff point of feeding the 0.2% d-Trp diet. Urinary excretion of 3-HK increased according to the increase in d-Trp intake. Urinary excretion of 3-HA increased at the cutoff point of feeding the 0.3% d-Trp diet. We calculated the ratios of urinary levels of 3-HK/Kyn and 3-HK/3-HA. The ratio of urinary levels of 3-HK/Kyn remained constant regardless of d-Trp intake. The ratio of urinary levels of 3-HK/3-HA had a cutoff point at feeding of the 0.3% d-Trp diet. In this regard, 3-HK and 3-HA in acidified urine were stable for $6 mo if urine samples were stored at 225˚C (data not shown). 3-HK (20) and 3-HA (21) in urine were simply measured by HPLC. Therefore, the current surrogate biomarker for predicting d-Trp toxicity is useful in a practical sense. The reaction 3-HK→3-HA is catalyzed by the pyridoxal phosphate (PLP)-dependent enzyme kynureninase (43) . Mammalian kynureninase preferentially catalyzes the hydrolytic cleavage of 3-HK to produce 3-HA and alanine (43) . Therefore, the name "kynureninase" is not suitable in mammals; instead it should be termed 3-hydroxykyn-ureninase. Increasing urinary levels of 3-HK, i.e., accumulation of 3-HK, implies kynureninase deficiency. However, a clear reason why such a cutoff point was obtained is not immediately obvious.
Thus, an important issue is to determine the over intake of d-Trp. We, then, propose the urinary ratio of 3HK/3-HA as an indicator to predict the over intake of d-Trp.
Funding sources
This study was a component of "Studies on the nutritional evaluation of amino acids and B-group vitamins" (principal investigator, Katsumi Shibata). A Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science supported this study.
Author contributions
KS designed the research. TO conducted the research. MS and TF assisted in the research. KS analyzed the data and drafted the manuscript, and was primarily responsible for the final content.
